Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0432222 (
SEM
)
47,337
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Vitamin A status has been assessed by studying plasma vitamin A and retinol binding protein (RBP) levels in premature infants receiving 7,500 IU vitamin A/d (
RDA
660-3,300 IU/d) and in control term babies during the 3 first months of life. Sampling was performed within the first week (D0-D7), between the 8th and the 30th day (D8-D30) and during the 2nd and the 3rd month of life (M2-M3). At D0-D7, vitamin A levels of the PTI group (28-32 weeks gestational age), PTII (33-36 weeks GA) and AT (control term newborn) were 242.1 +/- 20.5 (X +/-
SEM
), 176.1 +/- 12.3 and 213.1 +/- 17.1 micrograms/l respectively (P = 0.005). At D8-D30, these values were 264.2 +/- 26.0, 270.4 +/- 21.6 and 242.6 +/- 24.5 micrograms/l respectively (NS), and at M2-M3 234.2 +/- 21.6, 282.1 +/- 18.5 and 292.1 +/- 31.5 micrograms/l (NS). A significant difference was found between the values of the different dosage periods for PTII and AT groups; no difference in RBP levels was found either between groups or between dosage periods. At birth, our results show that the RBP synthesis is not closely linked to gestational age. The plasma vitamin A levels which rely on foetal stores and therefore on transplacental passage and on peripheral tissue requirements are low at 33-36 weeks gestational age. With a 7,500 IU daily supplement, excessively high vitamin A levels were not observed in premature infants; vitamin A and RBP levels in premature infants receiving supplement are not different from controls despite the 8-12-week term high vitamin A supply.
...
PMID:[Vitamin A status in full-term and premature infants]. 217 49
To determine the influence of zinc intake on copper excretion and retention, nine men consumed diets containing 2.6 mg of copper/day and 1.8, 4.0, 6.0, 8.0, 18.5 or 20.7 mg of zinc/day for one- or two-week periods in a 63-day study. Copper and zinc in the diet and copper in plasma were determined weekly; fecal copper was determined daily and averaged within each week. The weekly mean (+/-
SEM
) plasma copper concentrations (81 +/- 3.3 to 100 +/- 5.8 micrograms/dl) remained within the normal range throughout the study. Fecal copper and apparent copper retention were influenced by the level of dietary zinc and the duration it was fed. When 18.5 mg of zinc/day was fed for two consecutive weeks following a lower zinc intake, fecal copper was elevated and apparent copper retention was reduced after a one-week lag. Thus, an intake of zinc only 3.5 mg/day above the
RDA
for men reduced apparent retention of copper at an intake of 2.6 mg/day.
...
PMID:Effect of zinc intake on copper excretion and retention in men. 396 37
Food and fluid intake of 2 male cyclists was assessed to describe dietary intakes of athletes participating in an endurance ride. Cyclists rode 15 to 18 hr each day for 10 days to travel 2,050 miles on the original Pony Express Trail over seven major mountain ranges. Food and fluids were weighed or measured by researchers. Average kilocalorie intake was 7,125 +/- 340 (M +/-
SEM
), or 113 kcal/kg/day. Percentages of protein, carbohydrate, and fat kilocalories were 10, 63, and 27, respectively, with 44% of the carbohydrate kilocalories from simple sugars, cookies, sweetened drinks, and candy. Vitamin and mineral intakes were two to three times the
RDA
for most vitamins and minerals. Total fluid intake averaged 10.5 L per day with an average of 620 ml/hr of riding time. Of fluid intake, 54% was water. Cyclists traveling long distances need a variety of high-calorie foods and ample amounts of fluids to maintain performance for this type of event.
...
PMID:Dietary intake of two elite male cyclists during 10-day, 2,050-mile ride. 774 26
This study aimed at documenting airway inflammation and subepithelial collagen deposition in patients using only inhaled beta(2)-agonists with either recently diagnosed asthma (
RDA
: </= 2 yr, n = 16) or long-standing asthma (LSA: >/= 13 yr, n = 16) and at the influence of an intense inhaled corticosteroid (ICS) treatment on these parameters, in relation to changes in airway responsiveness. Patients had a methacholine inhalation test and a bronchoscopy with bronchial biopsies before and after an 8-wk treatment with inhaled fluticasone propionate (FP), 1,000 microgram/day. Baseline FEV(1) (mean +/-
SEM
) was normal and similar in both groups (
RDA
: 98.1 +/- 2.7, LSA: 94.5 +/- 4.6%). Geometric mean methacholine PC(20) was lower in LSA than in
RDA
(0.44 versus 3.37 mg/ml) at baseline and improved similarly by 1.85 and 1.86 double concentrations with FP treatment. PC(20) normalized (>/= 16 mg/ml) in five patients with
RDA
and two patients with LSA. Baseline mean bronchial cell counts (per mm(2) connective tissue surface) for CD3(+), CD4(+), CD8(+), CD25(+), EG1(+), CD45ro(+), and AA1(+) cells were similar in both groups. With FP, EG1(+) (p < 0.001), EG2(+) (p = 0.018), and AA1(+) counts (p = 0.009) decreased significantly in both groups while CD45ro(+) (p = 0.02) counts decreased only in LSA. Baseline type 1 and type 3 collagen deposition underneath the basement membrane was similar in
RDA
and LSA and did not change significantly after FP. This study shows that recent compared to long-standing mild asthma is associated with a similar degree of airway inflammation and subepithelial fibrosis, and a similar improvement in airway hyperresponsiveness after 8 wk on high-dose ICS. It also indicates that once asthma becomes symptomatic, airway responsiveness cannot normalize in most subjects over such a time period, even with a high dose of ICS.
...
PMID:Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. 1102 36